Position in GMAB
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$118,442,376
+$10,862,596 QoQ
Shares Held
4,414,550
+26.4% QoQ
Ownership
0.719%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,448,283,094 across 327 Biotechnology names. GMAB ranks #6 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,726,993 | $588,750,729 | |
| 2 | INCY |
Incyte Corp
|
3,651,532 | $343,682,191 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
5,682,783 | $229,072,982 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421,688 | $188,300,559 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
819,374 | $154,902,654 | |
| 6 | GMAB |
Genmab A/S
This page
|
4,414,550 | $118,442,376 | |
| 7 | INVA |
Innoviva, Inc.
|
4,055,632 | $94,496,225 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,036,495 | $64,988,236 |
All Filings in GMAB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $118,442,376 | 4,414,550 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $107,579,780 | 3,492,850 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $86,536,723 | 2,821,543 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $57,161,055 | 2,766,750 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $44,296,813 | 2,262,350 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $40,198,750 | 1,926,150 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $43,553,114 | 1,786,428 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $36,751,594 | 1,462,459 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $40,635,726 | 1,358,600 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $47,594,432 | 1,494,800 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $41,406,980 | 1,174,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $31,894,191 | 839,100 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $39,632,896 | 1,049,600 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $50,461,866 | 1,190,700 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $29,443,932 | 916,400 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $31,846,698 | 980,200 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $39,381,930 | 1,088,500 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $42,503,264 | 1,074,400 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $39,277,560 | 898,800 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $36,130,467 | 884,900 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $32,577,209 | 992,300 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $53,313,392 | 1,311,200 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $60,889,752 | 1,663,200 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $37,383,957 | 1,103,097 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,144,596 | 148,400 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||